Skip to content

Clinical trials

Terminated Phase 1/2 Small Cell Lung Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 1/2 Status: Terminated Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20082
20091
20102
20121
20133
20143
20151
20163
20172
20182
20192
20202
20212
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
Eli Lilly and Company2
Incyte Corporation2
AbbVie1
Armando Santoro, MD1
Ascentage Pharma Group Inc.1
Bayer1
BioNTech SE1
Dartmouth-Hitchcock Medical Center1
Evopoint Biosciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma30
Carcinoma, Non-Small-Cell Lung6
Lung Neoplasms5
Carcinoma, Transitional Cell4
Melanoma4
Neoplasm Metastasis4
Squamous Cell Carcinoma of Head and Neck4
Breast Neoplasms3
Stomach Neoplasms3
Carcinoma, Merkel Cell2

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.